Hope in Myeloma: The Road to Long-Term Survival

Cesar Rodriguez, MD

In this episode, we sit down with Dr. Cesar Rodriguez of Mount Sinai Hospital in New York, NY to discuss the evolving landscape of myeloma treatment. Groundbreaking innovations are bringing new hope to patients and caregivers. Dr. Rodriguez breaks down the latest advancements in immunotherapy, including CAR T-cell therapy and bispecific antibodies. Hear how researchers and physicians are working to make myeloma into a manageable, long-term disease, while ultimately searching for a cure.

CLICK HERE to participate in our episode survey.

Mentioned on this episode: 

Additional LLS Support Resources: 

Supported by Genentech, A Member of the Roche Group; and Johnson & Johnson.

6 Comments

    1. Hi Carol,

      We’re so sorry that the audio cut off. Rest assured, we are working on the technical difficulties and will get the full audio up and running shortly. Please check back!

  1. I enjoyed this podcast and learned new things. I believe it was cut off before he was done explaining the treatment care after an autologous
    SCT. I would like to hear the treatment…if possbile.

    1. Hi Susan,

      We’re so sorry that the audio cut off. Rest assured, we are working on the technical difficulties and will get the full audio up and running shortly. Please check back!

  2. Thank so much for the information that DR. Cesar Rodriguez gave. I really appreciated.💖💖💖💖💖💖

Leave a Comment

Your email address will not be published. Required fields are marked *